BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 20101720)

  • 21. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological substrates of cognitive decline in Alzheimer's disease.
    Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C
    Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
    Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
    Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.
    Dickson DW
    Neurobiol Aging; 1997; 18(4 Suppl):S21-6. PubMed ID: 9330981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biological significance of neuropathological lesions in Alzheimer's disease.
    Mori H
    Neurobiol Aging; 1997; 18(4):379-82; discussion 389-92. PubMed ID: 9330966
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.
    Papaioannou N; Tooten PC; van Ederen AM; Bohl JR; Rofina J; Tsangaris T; Gruys E
    Amyloid; 2001 Mar; 8(1):11-21. PubMed ID: 11293821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reanalysis of the first case of Alzheimer's disease.
    Graeber MB; Mehraein P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():10-3. PubMed ID: 10654094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.
    Cummings BJ; Pike CJ; Shankle R; Cotman CW
    Neurobiol Aging; 1996; 17(6):921-33. PubMed ID: 9363804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The search for diagnostic criteria in Alzheimer's disease: an update.
    Prayson RA; Estes ML
    Cleve Clin J Med; 1994; 61(2):115-22; quiz 162. PubMed ID: 8194175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
    Hyman BT
    Neurobiol Aging; 1997; 18(4 Suppl):S27-32. PubMed ID: 9330982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap.
    Urasaki K; Kuriki K; Namerikawa M; Satoh S; Ikeguchi K; Fukayama M; Saito K; Nakano I
    Neuropathology; 2000 Sep; 20(3):233-8. PubMed ID: 11132941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a neuropathology difference between mild cognitive impairment and dementia?
    Haroutunian V; Hoffman LB; Beeri MS
    Dialogues Clin Neurosci; 2009; 11(2):171-9. PubMed ID: 19585952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.